Human erythrocytes and neuroblastoma cells are affected in vitro by Au(III) ions

Biochemical and Biophysical Research Communications

Volumn 397, Issue 2, 2010, Pages 226-231

  Suwalsky, Mario ^a   González, Raquel ^a   Villena, Fernando ^a   Aguilar, Luis F ^b   Sotomayor, Carlos P ^b   Bolognin, Silvia ^c   Zatta, Paolo ^c  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Au(III); Erythrocyte membrane; Gold; Neuroblastoma; Phospholipid bilayer

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIMYRISTOYLPHOSPHATIDYLETHANOLAMINE; GOLD CHLORIDE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; GOLD DERIVATIVE; ION;

ARTICLE; CELL INTERACTION; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SHAPE; ERYTHROCYTE STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID BILAYER; MOLECULAR DYNAMICS; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION; CELL SURVIVAL; DRUG EFFECT; ERYTHROCYTE; FLUORESCENCE; TUMOR CELL LINE; ULTRASTRUCTURE;

ANTICARCINOGENIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FLUORESCENCE; GOLD COMPOUNDS; HUMANS; IONS; MICROSCOPY, ELECTRON, SCANNING; X-RAY DIFFRACTION;

EID: 77955503453     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.05.089     Document Type: Article

References (36)

1. A. Burke, E. Smyth, G.A. FitzGerald, Analgesic-antipyretic agents; pharmacotherapy of gout, in: L.L. Brunton (Ed.), Goodman & Gilman's the Pharmacological Basis of Therapeutics, 11th ed., McGraw-Hill, 2006, p. 706.
2. I. Ott, On the medicinal chemistry of gold complexes as anticancer drugs, Coord. Chem. Rev. 253 (2009) 1670-1681.
3. R.W.-Y. Sun, C.-M. Che, The anticancer properties of gold(III) compounds with dianionic porphyrin and tetradentate ligands, Coord. Chem. Rev. 253 (2009) 1682-1691.
4. A. Casini, C. Hartinger, C. Gabbiani, E. Mini, P.J. Dyson, B.K. Keppler, L. Messori, Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action, J. Inorg. Biochem. 102 (2008) 564-575.
5. R. Goyer, Toxic effects of metals, in: C.D. Klaasen, M.A. Amdur, J. Dull (Eds.), Casarett and Doull's Toxicology: The Basic Science of Poisons, MacMillan, 1986, pp. 582-635.
6. A.G. Fam, D.A. Gordon, J. Sarkozi, G.R. Blais, P.W. Cooper, M. Harth, A.J. Lewis, Neurological complications associated with gold therapy for rheumatoid arthritis, J. Rheumatol. 11 (1984) 700-706.
7. J.A. Garrido, M.V. Rorres-Pardo, D. Solá, C. Marsal, A. Alvarez, A. Lozano, Myokimia induced by gold salts, Neurología 10 (1995) 235-237.
8. K. Hashimoto, C.E. Whitehurst, T. Matsubara, K. Hirohaka, P.E. Lipsky, Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C, J. Clin. Invest. 89 (1992) 1839-1848.
9. A. Kumar-Mangalam, A. Aggarwal, S. Naik, Gold sodium thiomalate (GSTM) inhibits lipopolysaccharide stimulated tumor necrosis factor-alpha through ceramide pathway, Cell Immunol. 219 (2002) 1-10.
10. Z.Y. Wang, A. Morinobu, S. Kawano, J. Saegusa, B. Wang, S. Kumagai, Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes, Clin. Exp. Rheumatol. 20 (2002) 683-688.
11. M.P. Rigobello, G. Scutari, R. Rosolo, A. Bindoli, Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative, Br. J. Pharmacol. 136 (2002) 1162-1168.
12. C.F. Shaw III, The Biochemistry of Gold, in: H. Schmidbauer (Ed.), Gold: Chemistry, Biochemistry and Technology, Wiley, 1999, pp. 259-308.
13. J.M. Boon, B.D. Smith, Chemical control of phospholipid distribution across bilayer membranes, Med. Res. Rev. 22 (2002) 251-281.
14. P.F. Devaux, A. Zachowsky, Maintenance and consequences of membrane phospholipids asymmetry, Chem. Phys. Lipids 73 (1994) 107-120.
15. 2+ exerts stronger structural effects than the Mn-citrate complex on the human erythrocyte membrane and molecular models, J. Inorg. Biochem. 104 (2010) 55-61.
16. M. Suwalsky, M. Muñoz, S. Mennickent, C.P. Sotomayor, S. Bolognin, P. Zatta, Structural effects of verapamil on cell membranes and molecular models, J. Chil. Chem. Soc. 55 (2010) 1-4.
17. M. Suwalsky, R. González, F. Villena, L.F. Aguilar, C.P. Sotomayor, S. Bolognin, P. Zatta, Structural effects of tetrachloroauric acid on cell membranes and molecular models, Coord. Chem. Rev. 253 (2009) 1599-1606.
18. M. Suwalsky, F. Villena, C.P. Sotomayor, S. Bolognin, P. Zatta, Human cells and cell membrane molecular models are affected in vitro by chlorpromazine, Biophys. Chem. 135 (2008) 7-13.
19. M. Suwalsky, Phospholipid bilayers, in: J.C. Salamone (Ed.), Polymeric Materials Encyclopedia, CRC Press, 1996, pp. 5073-5078.
20. R. Koynova, M. Caffrey, Phases and phase transitions of the phosphatidylcholines, Biochim. Biophys. Acta 1376 (1998) 91-145.
21. T. Parasassi, E. Gratton, Membrane lipid domains and dynamics as detected by laurdan fluorescence, J. Fluoresc. 5 (1995) 59-69.
22. J.T. Dodge, C. Mitchell, D.J. Hanahan, The preparation and chemical characterization of haemoglobin-free ghosts of human erythrocytes, Arch. Biochem. Biophys. 100 (1963) 119-130.
23. J.R. Lakowicz, in: Principles of Fluorescence Spectroscopy, Plenum, 1999.
24. T. Parasassi, G. De Stasio, A. D'Ubaldo, E. Gratton, Phase fluctuation in phospholipid membranes revealed by laurdan fluorescence, Biophys. J. 57 (1990) 1179-1186.
25. M.S. Shearman, S.R. Hawtin, V.J. Tailor, The intracellular component of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides, J. Neurochem. 65 (1995) 218-227.
26. J.M. Campbell, J. Reglinski, W.E. Smith, D. Porter, R.D. Sturrock, Action of sodium aurothiomalate on erythrocyte-membrane, Ann. Rheum. Dis. 51 (1992) 969-971.
27. Y. Zhang, E.V. Hess, K.G. Pryhuber, J.G. Dorsey, K. Tepperman, R.C. Elder, Gold binding sites in red blood cells, Inorg. Chim. Acta 229 (1995) 271-280.
28. 2+ entry into and subsequent suicidal death of erythrocytes, Toxicology 244 (2008) 271-279.
29. H.T. Evans, Ionic radii, in: D.R. Lide, (Ed. in Cheif), Handbook of Chemistry and Physics, CRC, 1995-1996, pp. 12-14.
30. M.P. Sheetz, S.J. Singer, Biological membranes as bilayer couples, a molecular mechanism of drug-erythrocyte induced interactions, Proc. Natl. Acad. Sci. USA 71 (1974) 4457-4461.
31. G. Lim, M. Wortis, R. Mukhopadhyay, Stomatocyte-discocyte-echinocyte sequence of the human red blood cell: evidence for the bilayer-couple hypothesis from membrane mechanics, Proc. Natl. Acad. Sci. USA 99 (2002) 16766-16769.
32. S.L. Winski, D.E. Carter, Arsenate toxicity in human erythrocytes: characterization of morphological changes and determination of the mechanism of damage, J. Toxicol. Environ. Health A 53 (1998) 345-355.
33. S. Svetina, D. Kuzman, R.E. Waugh, P. Zibert, B. Zeks, The cooperative role of membrane skeleton and bilayer in the mechanical behaviour of red blood cells, Bioelectrochemistry 62 (2004) 107-113.
34. C. Lasagna-Reeves, D. Gonzalez-Romero, M.A. Barria, I. Olmedo, A. Clos, V.M. Sadagopa Ramanujam, A. Urayama, L. Vergara, M.J. Kogan, C. Soto, Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice, Biochem. Biophys. Res. Commun. 393 (2010) 649-655.
35. M.J. Heath, G.T. Gillet, A.J. Swannell, C.R. Williams, T. Palmer, Patterns of gold levels in urine, serum, and saliva in patients with rheumatoid arthritis undergoing chrysotherapy, Ann. Rheum. Dis. 46 (1987) 827-829.
36. Martindale, The Extra Pharmacopoeia, thirtieth ed., The Pharmaceutical Press, London, 1993. p. 7.